INMB Gross Margin

The Gross Margin of INmune Bio Inc (INMB) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

INMB Gross Margin - Historical Value

Date	Value
2024-12-31	7775.20%

INMB Gross Margin - Peers Comparison

Ticker	Name	Value
950220.KQ	Neoimmunetech Inc	7775.20%
AMGN	Amgen Inc	61.53%
CYCN	Cyclerion Therapeutics Inc	7775.20%
MRZM	Marizyme Inc	70.87%
950160.KQ	Kolon TissueGene Inc	11.72%
ATOS	Atossa Therapeutics Inc	100.00%
CELC	Celcuity Inc	7775.20%
PDSB	PDS Biotechnology Corp	7775.20%
SYBX	Synlogic Inc	7775.20%
ABBV	Abbvie Inc	69.99%
ANIX	Anixa Biosciences Inc	97.00%
CRVS	Corvus Pharmaceuticals Inc	7775.20%
EVAX	Evaxion Biotech A/S	7775.20%
LUMO	Lumos Pharma Inc	7775.20%
PTN	Palatin Technologies Inc	97.83%
AEZS.TO	Aeterna Zentaris Inc	95.06%
ATNF	180 Life Sciences Corp	7775.20%
DYAI	Dyadic International Inc	65.82%
LPTX	Leap Therapeutics Inc	7775.20%
ONC.TO	Oncolytics Biotech Inc	7775.20%
PHGE	Biomx Inc	7775.20%
GILD	Gilead Sciences Inc	78.26%
MRNA	Moderna Inc	70.06%
REGN	Regeneron Pharmaceuticals Inc	87.01%
WLLW.TO	Willow Biosciences Inc	-809.99%
950200.KQ	Psomagen Inc	23.13%
ARAV	Aravive Inc	7775.20%
ATNM	Actinium Pharmaceuticals Inc	100.00%
TCON	TRACON Pharmaceuticals Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
SLS	Sellas Life Sciences Group Inc	90.00%
ALRN	Aileron Therapeutics Inc	7775.20%
AYLA	Old Ayala Inc	-
BCLI	Brainstorm Cell Therapeutics Inc	7775.20%
LGVN	Longeveron Inc	78.76%
PSTI	Pluristem Therapeutics Inc	100.00%
SCPS	Scopus Biopharma Inc	7775.20%